المؤلفون: Yuichiro Yamada, Kenta Murotani, Yusuke Seino, Yutaka Seino, Minori Ishitobi, Yuji Yamazaki, Yuuka Fujiwara, Ryota Usui, Yoshiyuki Hamamoto, Hitoshi Kuwata, Sodai Kubota, Daisuke Yabe, Takeshi Kurose, Takuya Haraguchi, Saki Kubota-Okamoto

المصدر: Journal of Diabetes Investigation
Journal of Diabetes Investigation, Vol 12, Iss 12, Pp 2162-2171 (2021)

مصطلحات موضوعية: Blood Glucose, Male, 0301 basic medicine, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Glucagon-Like Peptides, Gastric emptying, Type 2 diabetes, chemistry.chemical_compound, 0302 clinical medicine, Japan, Insulin, Prospective Studies, digestive, oral, and skin physiology, Articles, General Medicine, Middle Aged, Postprandial Period, Clinical Science and Care, Postprandial, GLP‐1 receptor agonist, Female, Original Article, hormones, hormone substitutes, and hormone antagonists, medicine.drug, Adult, endocrine system, medicine.medical_specialty, Recombinant Fusion Proteins, 030209 endocrinology & metabolism, Gastric Inhibitory Polypeptide, Diseases of the endocrine glands. Clinical endocrinology, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, Lixisenatide, Internal medicine, islet hormones, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Glucagon-like peptide 1 receptor, Liraglutide, business.industry, RC648-665, Glucagon, medicine.disease, Immunoglobulin Fc Fragments, 030104 developmental biology, Endocrinology, Diabetes Mellitus, Type 2, chemistry, Dulaglutide, Apolipoprotein B-48, Peptides, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::306175bf3a5c32c1eda622a58314861dTest
https://doi.org/10.1111/jdi.13598Test

المؤلفون: Sharon Fruh, Lawrence Herman, Angela K. Fitch, Jamy D. Ard

المصدر: Advances in Therapy

مصطلحات موضوعية: Weight loss, 030213 general clinical medicine, medicine.medical_specialty, Glucagon-Like Peptides, Glucagon-like peptide 1 receptor agonist, Review, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, 0302 clinical medicine, Pharmacotherapy, Diabetes mellitus, Weight management, medicine, Humans, Hypoglycemic Agents, Pharmacology (medical), Obesity, Intensive care medicine, Adverse effect, Liraglutide, business.industry, Semaglutide, Antiobesity medication, General Medicine, medicine.disease, Diabetes Mellitus, Type 2, Pharmaceutical Preparations, 030220 oncology & carcinogenesis, medicine.symptom, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25d91085eb75600f119297f1f814cc0bTest
https://doi.org/10.1007/s12325-021-01710-0Test

المؤلفون: Mae Sheikh-Ali, Stephanie Niman, Rebecca F Goldfaden, Jessica Reid, Jennifer Hardy, David Sutton, Rushab Choksi

المصدر: Drugs in R&D

مصطلحات موضوعية: medicine.medical_specialty, Glucagon-Like Peptides, Administration, Oral, Review Article, Hypoglycemia, 030226 pharmacology & pharmacy, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, 0302 clinical medicine, Pharmacotherapy, medicine, Humans, Hypoglycemic Agents, Intensive care medicine, Glycemic, 030203 arthritis & rheumatology, Pharmacology, Liraglutide, business.industry, Semaglutide, Type 2 Diabetes Mellitus, medicine.disease, Regimen, Diabetes Mellitus, Type 2, Dulaglutide, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8b190df6ae0329f984f158d1ceb5f16Test
https://doi.org/10.1007/s40268-021-00341-8Test

المؤلفون: Sofie Gydesen, Anna Thorsø Larsen, Nina Sonne, Kim Henriksen, Morten A. Karsdal

المصدر: BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Endocrine Disorders

مصطلحات موضوعية: Blood Glucose, Male, 0301 basic medicine, Agonist, medicine.medical_specialty, medicine.drug_class, Endocrinology, Diabetes and Metabolism, Glucagon-Like Peptides, Amylin, 030209 endocrinology & metabolism, Diet, High-Fat, lcsh:Diseases of the endocrine glands. Clinical endocrinology, Glucagon-Like Peptide-1 Receptor, Rats, Sprague-Dawley, 03 medical and health sciences, 0302 clinical medicine, Weight loss, Internal medicine, Weight Loss, Animals, Hypoglycemic Agents, Medicine, Obesity, Calcitonin receptor, Glucagon-like peptide 1 receptor, Amylin Receptor Agonists, lcsh:RC648-665, Gastric emptying, business.industry, Liraglutide, digestive, oral, and skin physiology, DACRA, Glucagon secretion, Glucose tolerance, General Medicine, Glucose Tolerance Test, Receptors, Calcitonin, Receptors, Islet Amyloid Polypeptide, Rats, 030104 developmental biology, Endocrinology, Metabolome, Drug Therapy, Combination, medicine.symptom, business, GLP-1, Research Article, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c2adf23bbf84aa4d57fac2c77590782Test
https://doaj.org/article/c71fe40f440c43deb8dae3b003dd4193Test

المؤلفون: Juris J. Meier

المصدر: Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology

مصطلحات موضوعية: 030213 general clinical medicine, Endocrinology, Diabetes and Metabolism, Injections, Subcutaneous, efficacy, Glucagon-Like Peptides, Administration, Oral, 030209 endocrinology & metabolism, Review, Pharmacology, Glucagon-Like Peptide-1 Receptor, Diseases of the endocrine glands. Clinical endocrinology, 03 medical and health sciences, body weight, oral, 0302 clinical medicine, Endocrinology, glycated hemoglobin (HbA1c), medicine, Empagliflozin, Humans, Hypoglycemic Agents, Insulin, Canagliflozin, Glycated Hemoglobin, semaglutide, Insulin glargine, Liraglutide, business.industry, Semaglutide, RC648-665, glucagon-like peptide-1 receptor agonist (GLP-1RA), Diet, Exercise Therapy, Treatment Outcome, Clinical Trials, Phase III as Topic, Diabetes Mellitus, Type 2, Research Design, Sitagliptin, Quality of Life, Dulaglutide, subcutaneous, type 2 diabetes, business, Exenatide, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5701b067c851c878a8cc55b425ac7f47Test
https://www.frontiersin.org/articles/10.3389/fendo.2021.645617/fullTest

المؤلفون: Benjamin Wolthers, Søren Rasmussen, Vlado Perkovic, Thomas Idorn, John B. Buse, Lawrence A. Leiter, Richard E. Pratley, Tina Vilsbøll, Johannes F.E. Mann

المصدر: Diabetes, Obesity & Metabolism
Mann, J F E, Buse, J B, Idorn, T, Leiter, L A, Pratley, R E, Rasmussen, S, Vilsbøll, T, Wolthers, B & Perkovic, V 2021, ' Potential kidney protection with liraglutide and semaglutide : Exploratory mediation analysis ', Diabetes, Obesity and Metabolism, vol. 23, no. 9, pp. 2058-2066 . https://doi.org/10.1111/dom.14443Test

مصطلحات موضوعية: medicine.medical_specialty, kidney mediation, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, glucagon-like peptide-1 receptor agonist, Glucagon-Like Peptides, Renal function, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Kidney, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Internal medicine, glucagon‐like peptide‐1 receptor agonist, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Renal replacement therapy, Creatinine, liraglutide, Mediation Analysis, semaglutide, business.industry, Semaglutide, Original Articles, medicine.disease, Blood pressure, chemistry, Diabetes Mellitus, Type 2, Albuminuria, Original Article, type 2 diabetes, medicine.symptom, business, chronic kidney disease, Kidney disease

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a8977c898c125452c9a079b84a9fc59Test
https://pubmed.ncbi.nlm.nih.gov/34009708Test

المؤلفون: Mervete Miftaraj, Stefan Franzén, Björn Eliasson, Anders Toll, Jeremie Lebrec, Ann-Marie Svensson

المصدر: Diabetes, Obesity & Metabolism

مصطلحات موضوعية: medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Population, Glucagon-Like Peptides, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Drug Administration Schedule, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, Lixisenatide, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, GLP‐1 analogue, Internal medicine, Internal Medicine, medicine, Humans, Hypoglycemic Agents, education, Retrospective Studies, Sweden, antidiabetic drug, education.field_of_study, population study, Liraglutide, business.industry, Original Articles, medicine.disease, Discontinuation, Diabetes Mellitus, Type 2, chemistry, Propensity score matching, Original Article, Dulaglutide, type 2 diabetes, business, Exenatide, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aeac7d5bfcd2c99670139bdc98ad5b5Test
https://doi.org/10.1111/dom.14276Test

المؤلفون: Hai Qian, Chunxia Liu, Yuxing Zou

المصدر: Expert Opinion on Therapeutic Patents. 30:781-794

مصطلحات موضوعية: endocrine system, medicine.medical_specialty, medicine.medical_treatment, Glucagon-Like Peptides, Peptide, Endogeny, Enteroendocrine cell, 01 natural sciences, Glucagon, Glucagon-Like Peptide-1 Receptor, Patents as Topic, 03 medical and health sciences, 0302 clinical medicine, Glucagon-Like Peptide 1, Internal medicine, Drug Discovery, medicine, Animals, Humans, Obesity, Receptor, Pharmacology, chemistry.chemical_classification, Insulin, digestive, oral, and skin physiology, General Medicine, Liraglutide, medicine.disease, 0104 chemical sciences, 010404 medicinal & biomolecular chemistry, Endocrinology, chemistry, 030220 oncology & carcinogenesis, Glucose-dependent insulinotropic polypeptide, Anti-Obesity Agents, Peptides, hormones, hormone substitutes, and hormone antagonists

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3afe6c00ed95b9c0aebc29e6077897d7Test
https://doi.org/10.1080/13543776.2020.1811851Test

المؤلفون: Amy Butts, Ji Hyun Chun

المصدر: Journal of the American Academy of Physician Assistants. 33:3-18

مصطلحات موضوعية: 0301 basic medicine, endocrine system, Recombinant Fusion Proteins, Glucagon-Like Peptides, Administration, Oral, Type 2 diabetes, Pharmacology, Hypoglycemia, Satiety Response, Glucagon-Like Peptide-1 Receptor, Injections, Nurse Assisting, 03 medical and health sciences, 0302 clinical medicine, Glucagon-Like Peptide 1, Weight Loss, medicine, Humans, Hypoglycemic Agents, Glycated Hemoglobin, Liraglutide, business.industry, Semaglutide, digestive, oral, and skin physiology, medicine.disease, Immunoglobulin Fc Fragments, Albiglutide, Glucose, Treatment Outcome, 030104 developmental biology, Diabetes Mellitus, Type 2, Tolerability, Heart Disease Risk Factors, Delayed-Action Preparations, 030220 oncology & carcinogenesis, Exenatide, Dulaglutide, Safety, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc4365755453b7e952d7b903e90d94b4Test
https://doi.org/10.1097/01.jaa.0000669456.13763.bdTest

المؤلفون: Jakob Wefers, Juris J. Meier, Michael A. Nauck, Daniel R. Quast

المصدر: Molecular Metabolism, Vol 46, Iss, Pp 101102-(2021)
Molecular Metabolism

مصطلحات موضوعية: Blood Glucose, 0301 basic medicine, Glucagon-Like Peptides, Review, Type 2 diabetes, Pharmacology, Cardiovascular System, chemistry.chemical_compound, 0302 clinical medicine, Glucagon-Like Peptide 1, Insulin, Neurodegenerative Diseases, Cardiovascular disease, Albiglutide, medicine.drug, lcsh:Internal medicine, Recombinant Fusion Proteins, Lixisenatide, 030209 endocrinology & metabolism, Glucagon-Like Peptide-1 Receptor, Glucagon-like peptide-1 receptor agonists, 03 medical and health sciences, medicine, Animals, Humans, Psoriasis, Dulaglutide, lcsh:RC31-1245, Molecular Biology, Gastric emptying, Liraglutide, business.industry, Semaglutide, Body Weight, Cell Biology, medicine.disease, Hypoglycemia, Immunoglobulin Fc Fragments, 030104 developmental biology, Diabetes Mellitus, Type 2, chemistry, Exenatide, Peptides, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::875775b98729f2e1bb80ab140f2751b8Test
http://www.sciencedirect.com/science/article/pii/S2212877820301769Test